UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000029348
Receipt number R000031896
Scientific Title A study of efficacy and safety of landiolol hydrochloride for pulmonary resection
Date of disclosure of the study information 2017/10/01
Last modified on 2018/10/29 11:15:04

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A study of efficacy and safety of landiolol hydrochloride for pulmonary resection

Acronym

A study of landiolol hydrochloride for pulmonary resection

Scientific Title

A study of efficacy and safety of landiolol hydrochloride for pulmonary resection

Scientific Title:Acronym

A study of landiolol hydrochloride for pulmonary resection

Region

Japan


Condition

Condition

patients who underwent pulmonary resection

Classification by specialty

Chest surgery Anesthesiology Operative medicine

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To investigate the outcome of patients who underwent pulmonary resection with/without landiolol hydrochloride

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

2-year relapse free survival rate

Key secondary outcomes

Relapse free survival, overall survival


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Medicine

Interventions/Control_1

landiolol hydrochloride

Interventions/Control_2

placebo

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit

85 years-old >

Gender

Male and Female

Key inclusion criteria

1. male and female under 85
2. ASA 1-2
3. patients who underwent pulmonary resection due to lung cancer

Key exclusion criteria

1. supraventricular arrhythmia including atrial fibrillation or atrial flutter
2. patients with sick sinus syndrome including patients with pacemaker implantation
3. patients with severe heart failure (Class III or higher NYHA cardiac function classification)
4. patients with second or higher degree atrioventricular block
5. moderate to severe valve disease
6. patients who have experienced acute cardiovascular events, cerebrovascular events, infectious inflammation within the past 60 days
7. patients with tendency of bradycardia (resting heart rate under 55 times/min)
8. patients with systolic blood pressure less than 80 mmHg
9. patients who had been administered beta blockers before surgery
10. patients with severe bronchial asthma
11. patients who had typical honeycomb lung due to obstructive pulmonary disease (COPD stage 2 or higher) or diffuse lung disease (IP)
12. patients whose cause of atrial fibrillation was identified as electrolyte abnormality, WPW syndrome or hyperthyroidism and so on
13. patients who had been administered antiarrhythmic drugs except for digitalis before pulmonary surgery
14. patients in whom beta-blockers are contraindicated
15. chronic inflammatory diseases
16. patients with severe hepatic impairment
17. patients with severe renal impairment
18. others, patients who are judged inappropriate for this study by principle investigator

Target sample size

64


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Atsuhiro Sakamoto

Organization

Nippon Medical School

Division name

Department of Anesthesiology

Zip code


Address

1-1-5, Sendagi, Bunkyo-ku, Tokyo

TEL

03-3822-2131

Email

no1-saka@nms.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Tomohiro Harada

Organization

Ono Pharmaceutical Co., Ltd.

Division name

Clinical Development Planning 2

Zip code


Address

8-2, Kyutaromachi 1-chome, Chuo-ku, Osaka-shi

TEL

06-6263-3902

Homepage URL


Email

t.harada@ono.co.jp


Sponsor or person

Institute

Nippon Medical School Hospital

Institute

Department

Personal name



Funding Source

Organization

Ono Pharmaceutical co.,ltd

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 10 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2017 Year 01 Month 20 Day

Date of IRB


Anticipated trial start date

2017 Year 01 Month 20 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2017 Year 09 Month 29 Day

Last modified on

2018 Year 10 Month 29 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000031896


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name